1. Academic Validation
  2. New imidazo[2,1- b]thiazole-based aryl hydrazones: unravelling their synthesis and antiproliferative and apoptosis-inducing potential

New imidazo[2,1- b]thiazole-based aryl hydrazones: unravelling their synthesis and antiproliferative and apoptosis-inducing potential

  • RSC Med Chem. 2020 Jul 22;11(10):1178-1184. doi: 10.1039/d0md00188k.
Mohd Adil Shareef 1 2 Ganthala Parimala Devi 1 2 Sunitha Rani Routhu 3 C Ganesh Kumar 3 Ahmed Kamal 2 4 Bathini Nagendra Babu 1 2
Affiliations

Affiliations

  • 1 Department of Fluoro-Agrochemicals , CSIR-Indian Institute of Chemical Technology , Tarnaka , Hyderabad , India . Email: bathini@iict.res.in.
  • 2 Academy of Scientific and Innovative Research , Ghaziabad 201 002 , India.
  • 3 Organic Synthesis and Process Chemistry Division , CSIR-Indian Institute of Chemical Technology , Tarnaka , Hyderabad 500007 , India.
  • 4 School of Pharmaceutical Education and Research (SPER) , Jamia Hamdard , New Delhi 110062 , India.
Abstract

Herein, we have designed and synthesized new imidazo[2,1-b]thiazole-based aryl hydrazones (9a-w) and evaluated their anti-proliferative potential against a panel of human Cancer cell lines. Among the synthesized compounds, 9i and 9m elicited promising cytotoxicity against the breast Cancer cell line MDA-MB-231 with IC50 values of 1.65 and 1.12 μM, respectively. Cell cycle analysis revealed that 9i and 9m significantly arrest MDA-MB-231 cells in the G0/G1 phase. In addition, detailed biological studies such as annexin V-FITC/propidium iodide, DCFH-DA, JC-1 and DAPI staining assays revealed that 9i and 9m triggered Apoptosis in MDA-MB-213 cells. Overall, the current work demonstrated the cytotoxicity and apoptosis-inducing potential of 9i and 9m in breast Cancer cells and suggested that they could be explored as promising antiproliferative leads in the future.

Figures